Novasep, a French provider of global manufacturing solutions for life science molecules and fine chemicals, has appointed Michel Spagnol as Chairman of the Supervisory Board, following the departure of Roger-Marc Nicoud, the Group's Founder.
Spagnol joined Novasep as CEO in June 2013. Since then, he has reinforced the executive management team with the appointments of Christian Thiry as Chief Financial Officer, Thierry Van Nieuwenhove as President of the Synthesis Business Unit and the promotion of Nadège Laborde as President of the Industrial Biotech Unit.
'Since October 2012, as Chairman of Novasep’s Supervisory Board, I have assisted the executive management team in order to ensure that my succession proceeds in the best possible conditions,' said Nicoud. 'Novasep achieved satisfying growth in 2013, and has promising projects underway and the necessary human and financial resources to achieve them. With the arrival of Michel Spagnol as CEO, I consider my support work to be completed. I have decided to devote myself entirely to other technical and scientific activities.'
